Literature DB >> 15595841

Impaired binding affinity of electronegative low-density lipoprotein (LDL) to the LDL receptor is related to nonesterified fatty acids and lysophosphatidylcholine content.

Sonia Benítez1, Virtudes Villegas, Cristina Bancells, Oscar Jorba, Francesc González-Sastre, Jordi Ordóñez-Llanos, José Luis Sánchez-Quesada.   

Abstract

The binding characteristics of electropositive [LDL(+)] and electronegative LDL [LDL(-)] subfractions to the LDL receptor (LDLr) were studied. Saturation kinetic studies in cultured human fibroblasts demonstrated that LDL(-) from normolipemic (NL) and familial hypercholesterolemic (FH) subjects had lower binding affinity than their respective LDL(+) fractions (P < 0.05), as indicated by higher dissociation constant (K(D)) values. FH-LDL(+) also showed lower binding affinity (P < 0.05) than NL-LDL(+) (K(D), sorted from lower to higher affinity: NL-LDL(-), 33.0 +/- 24.4 nM; FH-LDL(-), 24.4 +/- 7.1 nM; FH-LDL(+), 16.6 +/- 7.0 nM; NL-LDL(+), 10.9 +/- 5.7 nM). These results were confirmed by binding displacement studies. The impaired affinity binding of LDL(-) could be attributed to altered secondary and tertiary structure of apolipoprotein B, but circular dichroism (CD) and tryptophan fluorescence (TrpF) studies revealed no structural differences between LDL(+) and LDL(-). To ascertain the role of increased nonesterified fatty acids (NEFA) and lysophosphatidylcholine (LPC) content in LDL(-), LDL(+) was enriched in NEFA or hydrolyzed with secretory phospholipase A(2). Modification of LDL gradually decreased the affinity to LDLr in parallel to the increasing content of NEFA and/or LPC. Modified LDLs with a NEFA content similar to that of LDL(-) displayed similar affinity. ApoB structure studies of modified LDLs by CD and TrpF showed no difference compared to LDL(+) or LDL(-). Our results indicate that NEFA loading or phospholipase A(2) lipolysis of LDL leads to changes that affect the affinity of LDL to LDLr with no major effect on apoB structure. Impaired affinity to the LDLr shown by LDL(-) is related to NEFA and/or LPC content rather than to structural differences in apolipoprotein B.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15595841     DOI: 10.1021/bi048825z

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  15 in total

1.  HDL and electronegative LDL exchange anti- and pro-inflammatory properties.

Authors:  Cristina Bancells; José Luis Sánchez-Quesada; Ragnhild Birkelund; Jordi Ordóñez-Llanos; Sònia Benítez
Journal:  J Lipid Res       Date:  2010-07-20       Impact factor: 5.922

2.  Immunochemical analysis of the electronegative LDL subfraction shows that abnormal N-terminal apolipoprotein B conformation is involved in increased binding to proteoglycans.

Authors:  Cristina Bancells; Sònia Benítez; Jordi Ordóñez-Llanos; Katariina Öörni; Petri T Kovanen; Ross W Milne; José L Sánchez-Quesada
Journal:  J Biol Chem       Date:  2010-11-15       Impact factor: 5.157

3.  Effects of rosuvastatin on electronegative LDL as characterized by capillary isotachophoresis: the ROSARY Study.

Authors:  Bo Zhang; Akira Matsunaga; David L Rainwater; Shin-Ichiro Miura; Keita Noda; Hiroaki Nishikawa; Yoshinari Uehara; Kazuyuki Shirai; Masahiro Ogawa; Keijiro Saku
Journal:  J Lipid Res       Date:  2008-12-03       Impact factor: 5.922

4.  Aggregated electronegative low density lipoprotein in human plasma shows a high tendency toward phospholipolysis and particle fusion.

Authors:  Cristina Bancells; Sandra Villegas; Francisco J Blanco; Sonia Benítez; Isaac Gállego; Lorea Beloki; Montserrat Pérez-Cuellar; Jordi Ordóñez-Llanos; José Luis Sánchez-Quesada
Journal:  J Biol Chem       Date:  2010-07-29       Impact factor: 5.157

5.  2D-NMR reveals different populations of exposed lysine residues in the apoB-100 protein of electronegative and electropositive fractions of LDL particles.

Authors:  Francisco J Blanco; Sandra Villegas; Sònia Benítez; Cristina Bancells; Tammo Diercks; Jordi Ordóñez-Llanos; José L Sánchez-Quesada
Journal:  J Lipid Res       Date:  2010-01-28       Impact factor: 5.922

6.  Low density lipoprotein delays clearance of triglyceride-rich lipoprotein by human subcutaneous adipose tissue.

Authors:  Simon Bissonnette; Huda Salem; Hanny Wassef; Nathalie Saint-Pierre; Annie Tardif; Alexis Baass; Robert Dufour; May Faraj
Journal:  J Lipid Res       Date:  2013-02-17       Impact factor: 5.922

7.  Thermal stability of human plasma electronegative low-density lipoprotein: A paradoxical behavior of low-density lipoprotein aggregation.

Authors:  Anna Rull; Shobini Jayaraman; Donald L Gantz; Andrea Rivas-Urbina; Montserrat Pérez-Cuellar; Jordi Ordóñez-Llanos; Jose Luis Sánchez-Quesada; Olga Gursky
Journal:  Biochim Biophys Acta       Date:  2016-05-24

Review 8.  Lipoprotein-associated phospholipase A2: pathogenic mechanisms and clinical utility for predicting cardiovascular events.

Authors:  Vijay Nambi; Christie M Ballantyne
Journal:  Curr Atheroscler Rep       Date:  2006-09       Impact factor: 5.113

Review 9.  The underlying chemistry of electronegative LDL's atherogenicity.

Authors:  Liang-Yin Ke; Nicole Stancel; Henry Bair; Chu-Huang Chen
Journal:  Curr Atheroscler Rep       Date:  2014-08       Impact factor: 5.113

10.  Lp-PLA2 inhibition prevents Ang II-induced cardiac inflammation and fibrosis by blocking macrophage NLRP3 inflammasome activation.

Authors:  Si-Lin Lv; Zi-Fan Zeng; Wen-Qiang Gan; Wei-Qi Wang; Tie-Gang Li; Yu-Fang Hou; Zheng Yan; Ri-Xin Zhang; Min Yang
Journal:  Acta Pharmacol Sin       Date:  2021-07-05       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.